Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II lenalidomide monotherapy in relapsed/refractory mantle cell lymphoma
2007-005472-13Phase 2Completed
- Sponsor
- University Hospitals Plymouth
- Start
- Sep 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of lenalidomide in mantle cell lymphoma (MCL), sponsored by University Hospitals Plymouth. Primary endpoint: Disease progression. Started Sep 2008; status: completed.
02
Drugs
lenalidomide
03
Conditions
mantle cell lymphoma (MCL)
Beyond the preview
Go deeper on 2007-005472-13.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-005472-13.